Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenomic-Guided Therapy in Colorectal Cancer.
Diasio RB, Innocenti F, Offer SM. Diasio RB, et al. Among authors: innocenti f. Clin Pharmacol Ther. 2021 Sep;110(3):616-625. doi: 10.1002/cpt.2334. Epub 2021 Jul 10. Clin Pharmacol Ther. 2021. PMID: 34114648 Review.
The role of pharmacogenetics in cancer therapeutics.
Yong WP, Innocenti F, Ratain MJ. Yong WP, et al. Among authors: innocenti f. Br J Clin Pharmacol. 2006 Jul;62(1):35-46. doi: 10.1111/j.1365-2125.2006.02591.x. Br J Clin Pharmacol. 2006. PMID: 16842377 Free PMC article. Review.
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.
Cecchin E, D'Andrea M, Lonardi S, Zanusso C, Pella N, Errante D, De Mattia E, Polesel J, Innocenti F, Toffoli G. Cecchin E, et al. Among authors: innocenti f. Pharmacogenomics J. 2013 Oct;13(5):403-9. doi: 10.1038/tpj.2012.31. Epub 2012 Aug 7. Pharmacogenomics J. 2013. PMID: 22868256 Free PMC article.
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens.
Lévesque E, Bélanger AS, Harvey M, Couture F, Jonker D, Innocenti F, Cecchin E, Toffoli G, Guillemette C. Lévesque E, et al. Among authors: innocenti f. J Pharmacol Exp Ther. 2013 Apr;345(1):95-101. doi: 10.1124/jpet.112.202242. Epub 2013 Feb 5. J Pharmacol Exp Ther. 2013. PMID: 23386248 Free PMC article. Clinical Trial.
A novel UGT1 marker associated with better tolerance against irinotecan-induced severe neutropenia in metastatic colorectal cancer patients.
Chen S, Laverdiere I, Tourancheau A, Jonker D, Couture F, Cecchin E, Villeneuve L, Harvey M, Court MH, Innocenti F, Toffoli G, Lévesque E, Guillemette C. Chen S, et al. Among authors: innocenti f. Pharmacogenomics J. 2015 Dec;15(6):513-20. doi: 10.1038/tpj.2015.12. Epub 2015 Mar 17. Pharmacogenomics J. 2015. PMID: 25778466 Free PMC article.
412 results